This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $10,037.40 contract will provide the NIH with Qiagen's sample and assay technologies to support the agency's biomedical research, public health, and healthcare programs. The contract does not have a set-aside designation. Qiagen has a history of providing a range of products and services to federal...
This is a $17,029.90 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The award does not have a set-aside designation. Qiagen provides a range of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is associated with a larger Qiagen indefinite delivery vehicle that...
This is a $80,260 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The contract is not set aside and has a period of performance from March 28, 2019 to April 14, 2021. Qiagen, a global provider of sample and assay technologies, has delivered a range of products and services to federal agencies, including DNA/RNA extraction kits, next-generation sequencing equipment, bioinformatics software, and other...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract has a total ceiling value of $19,008.00 and a period of performance ending on March 30, 2026. The contract does not have a set-aside designation. Qiagen, LLC will provide a range of products and services to support the NIH's biomedical research, public health, and healthcare programs, including...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software....
This purchase order award from the Department of Health and Human Services' National Institutes of Health Clinical Center to Qiagen, LLC is for $10,847.20 to support library preparation in next generation sequencing assays for clinical center patients. Qiagen will provide products and services for DNA/RNA extraction and sample preparation to support the agency's biomedical research and public health programs. As an international provider of molecular diagnostics technologies, Qiagen has...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $22,324.00 contract is for the provision of various products and services to support the NIH's biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems,...
This is a $33,368.50 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract is for the provision of DNA isolation kits from November 1, 2024 to September 30, 2025. The award is not associated with a set-aside program. Qiagen has a history of providing a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare...
This $8,292.90 firm fixed-price federal Purchase Order contract was awarded on July 1, 2019 by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, to Qiagen, LLC for the provision of laboratory equipment and supplies. The contract has an ultimate completion date of July 7, 2020 and did not utilize any set-aside designations. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies, and has a history of serving as both...
This is a $10,768.00 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The contract is for the QCII TRANSLATIONAL 1,000 SAMPLES requirement, with a performance period ending on September 28, 2025. Qiagen has provided a range of goods and services to federal agencies in the past, including DNA/RNA extraction kits, next-generation...